Archives
Browse through our archives, either by category or month.
Categories
- Alzheimers (47)
- Business of Health (28)
- Cancer (93)
- Drug Development (26)
- Epilepsy (19)
- M&A (71)
- Neurological Disorders (28)
- News Wire (116)
- Pharmaceutical Industry (54)
Monthly Archives
- January 2009 (12)
- December 2008 (118)
- November 2008 (131)
- October 2008 (151)
- September 2008 (67)
The Last 30 Posts
- Pfizer CEO: Big Acquisitions Are an Option - Posted on 5 January 2009 - Comments (0)
- Pathway that Regulates Survival Factor Implicated in Parkinson’s - Posted on 5 January 2009 - Comments (0)
- Cancer cells ‘cheat suicide call’ - Posted on 5 January 2009 - Comments (0)
- Celgene warns that anticlot drug linked to deaths - Posted on 5 January 2009 - Comments (0)
- Pfizer Looks for a Better Way to Detect Drug Risks - Posted on 5 January 2009 - Comments (0)
- NICE issues new guidelines for better access to life-extending treatments for terminally ill patients - Posted on 5 January 2009 - Comments (0)
- FDA drug approvals up in 2008 - Posted on 5 January 2009 - Comments (0)
- FDA Approves Roche’s Assay that Tests Donated Blood for HIV, Hep B, and Hep C - Posted on 2 January 2009 - Comments (0)
- DNA Repair Genes Previously Linked to Cancer Are Not Statistically Significant - Posted on 2 January 2009 - Comments (0)
- The Biggest Spenders in R&D Collaborations - Posted on 2 January 2009 - Comments (0)
- FDA Panel to Weigh Fate of Heart Drug Prasugrel in February - Posted on 2 January 2009 - Comments (0)
- Equivocal Data on Plavix Flummox FDA, Doctors - Posted on 2 January 2009 - Comments (0)
- Why prostate cancer patients fail hormone deprivation therapy - Posted on 31 December 2008 - Comments (0)
- Grape extract kills cancer cells - Posted on 31 December 2008 - Comments (0)
- Possible New Target For Treating Breast Cancer - Posted on 31 December 2008 - Comments (0)
- Bayer to Abbott: You Owe Us for Humira - Posted on 31 December 2008 - Comments (0)
- Immune cells link to Parkinson’s - Posted on 30 December 2008 - Comments (0)
- 20% ‘have blood pressure gene’ - Posted on 30 December 2008 - Comments (0)
- President-Elect Obama’s Choices for Key Science Posts Hailed - Posted on 30 December 2008 - Comments (0)
- Bariatric Surgery Eases Diabetes in Obese Teens - Posted on 30 December 2008 - Comments (0)
- Genetic diseases may be tougher to crack, new research suggests - Posted on 29 December 2008 - Comments (0)
- Sleep gives brain disease warning - Posted on 29 December 2008 - Comments (0)
- This Year’s Life Science Discoveries - Posted on 29 December 2008 - Comments (0)
- FDA Roundup: Drugs for Depression, Diabetes and Psoriasis - Posted on 29 December 2008 - Comments (0)
- Blood flow key to Alzheimer’s - Posted on 29 December 2008 - Comments (0)
- Researchers Pinpoint Why Oligoendrocyte Precursor Cells do Not Develop in MS Patients - Posted on 24 December 2008 - Comments (0)
- AstraZeneca mulls entry into biosimilar market - Posted on 24 December 2008 - Comments (0)
- Celgene’s Vidaza approved in the EU - Posted on 24 December 2008 - Comments (0)
- Study yields mixed results for sanofi-aventis’ Multaq - Posted on 24 December 2008 - Comments (0)
- FDA warns against some diet pills sold on the Web - Posted on 23 December 2008 - Comments (0)
- Pfizer CEO: Big Acquisitions Are an Option
- Pathway that Regulates Survival Factor Implicated in Parkinson’s
- Cancer cells ‘cheat suicide call’
- Celgene warns that anticlot drug linked to deaths
- Pfizer Looks for a Better Way to Detect Drug Risks
- NICE issues new guidelines for better access to life-extending treatments for terminally ill patients
- FDA drug approvals up in 2008
- FDA Approves Roche’s Assay that Tests Donated Blood for HIV, Hep B, and Hep C
- DNA Repair Genes Previously Linked to Cancer Are Not Statistically Significant
- The Biggest Spenders in R&D Collaborations
- FDA Panel to Weigh Fate of Heart Drug Prasugrel in February
- Equivocal Data on Plavix Flummox FDA, Doctors
- Why prostate cancer patients fail hormone deprivation therapy
- Grape extract kills cancer cells
- Possible New Target For Treating Breast Cancer
- Brain Teasers
- Metformin may enhance activity of antibody in trials
- Lilly Breaks The Mold With Buy Of ImClone
- FDA approves AstraZeneca’s SEROQUEL XR
- Pharma Goes To Market
- Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals
- UCB says Keppra XR epilepsy drug approved in U.S
- Cash-Poor Biotech Firms Cut Research, Seek Aid
- Horse Race Begins for New Leaders at FDA and HHS
- Novartis Changes Division Heads, Plans U.S. Job Cuts
- China Biotech in Review: Deals, Developments and Financials
- Alzheimer’s disease: approaching time zero
- Johnson & Johnson Submits New Drug Application to FDA for Carisbamate
- Therapy For Alzheimer's Disease Confirmed
- GlaxoSmithKline's Lamictal Will Continue to Dominate in the Epilepsy Drug Market
- Bayer Pays $4M Upfront to Use ImmunoGen’s Technology for a Solid Tumor Target (4)
- Vimpat Approved in Europe (3)
- Lilly to Acquire ImClone Systems in $6.5 Billion Transaction (3)
- Pharma Goes To Market (3)
- Hyperactive Neurons and Amyloid, Side by Side (2)
- Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study (2)
- Dendreon Announces Interim Data from Phase 3 PROVENGE IMPACT Trial (2)
- FDA approves AstraZeneca’s SEROQUEL XR (2)
- Protein shown to play a key role in normal development of nervous system (2)
- Brain Teasers (2)
- Astellas and Maxygen Announce Global Development Agreement (1)
- Teva and Kowa Announce Strategic Partnership (1)
- Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals (1)
- China Biotech in Review: Deals, Developments and Financials (1)
- Eli Lilly, Deciphera enter oncology collaboration (1)
